Technology Solutions

Certara launches Phoenix Technology Services for R&D productivity

Thursday, February 25, 2016

Certara, a global biosimulation technology-enabled drug development company, today announced the introduction of Phoenix Technology Services. These services, led and implemented by Certara’s team of biosimulation (modeling and simulation) experts, include customized and ready-to-use solutions that span the breadth of the Phoenix platform.

[Read More]

Icon releases Flex Advantage for patient randomization

Tuesday, February 2, 2016

Icon, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has launched Flex Advantage, a next-generation Interactive Response Technology (IRT) platform that offers enhanced randomization and clinical supply management capabilities and supports the execution of adaptive trials.

[Read More]

Three Questions: Drew Schiller, Validic

Monday, January 25, 2016

CWWeekly presents this feature as a way to shine the spotlight on issues faced by executives in the clinical trials space. Writer Suz Redfearn spoke with Drew Schiller, chief technology officer and co-founder of Validic, an IT company that con­nects data from wearable and medical devices to companies across the healthcare ecosystem.

[Read More]

Veeva Systems launches new TMF Maturity Model

Monday, January 25, 2016

Veeva Systems has introduced the Veeva TMF Maturity Model, a complimentary consultative service designed to assess the state of a life sciences organization’s trial master file (TMF) strategy and provide a roadmap for improvement. The Veeva TMF Maturity Model gives practical, step-by-step guidance to help companies transform their TMF from a static archive into a strategic asset that can help increase the efficiency of clinical trials. It is available as a self-service online tool or as a more detailed, in-person evaluation with a seasoned subject matter expert.

[Read More]

UCL launches $55M technology investment fund

Wednesday, January 20, 2016

UCL is launching the UCL Technology Fund to invest £50 million ($55 million) in commercializing its research emerging over the next five years. The Fund will be used to support academics whose research has commercial potential, with funding for early stage proof-of-concept, licensing projects and new spinout companies.

[Read More]